BELBUCA 150 MCG
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) : 150 MCG · DIN 02465248 · PURDUE PHARMA
Health Canada status: CANCELLED POST MARKET
What is BELBUCA?
BELBUCA 150 MCG contains BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) : 150 MCG. It is listed in the Health Canada Drug Product Database under DIN 02465248, held by PURDUE PHARMA, supplied as FILM, SOLUBLE for BUCCAL administration. Health Canada currently lists it as cancelled post market, status dated 31-May-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02465248 |
|---|---|
| Brand name | BELBUCA |
| Generic / active ingredient | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) : 150 MCG |
| Manufacturer | PURDUE PHARMA |
| Strength | 150 MCG |
| Dosage form | FILM, SOLUBLE |
| Route of administration | BUCCAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AE01 BUPRENORPHINE |
| AHFS class | 28:08.12 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-May-2019 |
| Original market date | 2018-01-17 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N02AE01 BUPRENORPHINE. 4 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BUTRANS 10 | 10 MCG | PATCH | PURDUE PHARMA | MARKETED | DIN 02341212 |
| BUTRANS 15 | 15 MCG | PATCH | PURDUE PHARMA | MARKETED | DIN 02450771 |
| BUTRANS 20 | 20 MCG | PATCH | PURDUE PHARMA | MARKETED | DIN 02341220 |
| BUTRANS 5 | 5 MCG | PATCH | PURDUE PHARMA | MARKETED | DIN 02341174 |
| BAR-BUPRENORPHINE | 10 MCG | PATCH | BARD PHARMACEUTICALS (1990) INC | CANCELLED PRE MARKET | DIN 02493616 |
| BAR-BUPRENORPHINE | 15 MCG | PATCH | BARD PHARMACEUTICALS (1990) INC | CANCELLED PRE MARKET | DIN 02493624 |
| BAR-BUPRENORPHINE | 20 MCG | PATCH | BARD PHARMACEUTICALS (1990) INC | CANCELLED PRE MARKET | DIN 02493632 |
| BAR-BUPRENORPHINE | 5 MCG | PATCH | BARD PHARMACEUTICALS (1990) INC | CANCELLED PRE MARKET | DIN 02493608 |
| BELBUCA | 300 MCG | FILM, SOLUBLE | PURDUE PHARMA | CANCELLED POST MARKET | DIN 02465256 |
| BELBUCA | 450 MCG | FILM, SOLUBLE | PURDUE PHARMA | CANCELLED POST MARKET | DIN 02465264 |
Who else supplies BUPRENORPHINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BUPRENORPHINE appears in 392 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.